Morning Buzz: Immunomedics (IMMU), SunPower (SPWR), Amedica Corp (AMDA), Progenics Pharma (PGNX)
July 28, 2015 at 09:20 AM EDT
Immunomedics Inc. (IMMU) is one of today’s notable stocks in decline, down as much as 45 percent following Belgium’s UCB announcement that its Phase 3 clinical trial program for Epratuzumab did not meet primary endpoint. Epratuzumab was licensed from Immunomedics. “Although we are disappointed with the results from the Phase 3 program, our commitment to […] View the full post at: Morning Buzz: Immunomedics (IMMU), SunPower (SPWR), Amedica Corp (AMDA), Progenics Pharma (PGNX) Related posts: SunPower Shows Solar Can Be Profitable Accounting Irregularities Eclipse SunPower Apache Corp. in final talks to buy Energy Corp’s shallow Gulf assets